Search
Search results
134 results found
Shiva and Sudha Swamynathan attend ISER 2024 meeting
Shiva and Sudha Swamynathan attended the 2024 ISER biennial meeting in Buenos Aires, Argentina where they presented their recent findings and interacted with colleagues from around the world. Shiva also chaired a session on corneal epithelial wound healing. It was a busy week of attending talks...
Farewell, Satinder!
After two years of post-doctoral training in our lab, Satinder Kaur is heading west to Stanford University, to continue her training and be closer to her husband! In the two years that she spent with us, Satinder produced high quality work that resulted in a first author review, one co-authored...
Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations.
Hersh, BP, NL Earl, RA Hauser, and M Stacy. 2010. “Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson’s Disease Patients With Motor Fluctuations.”. Mov Disord.
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.
Colosimo, C, P Martinez-Martin, G Fabbrini, RA Hauser, M Merello, J Miyasaki, W Poewe, et al. 2010. “Task Force Report on Scales to Assess Dyskinesia in Parkinson’s Disease: Critique and Recommendations.”. Mov Disord.
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.
Rascol, O, P Barone, RA Hauser, Y Mizuno, W Poewe, AH Schapira, L Salin, M Sohr, and C Debieuvre. 2010. “Efficacy, Safety, and Tolerability of Overnight Switching from Immediate- to Once Daily Extended-Release Pramipexole in Early Parkinson’s Disease.”. Mov Disord.
The independent influence of apathy and depression on cognitive functioning in Parkinson's disease
Butterfield, LC, CR Cimino, LE Oelke, RA Hauser, and J Sanchez-Ramos. 2010. “The Independent Influence of Apathy and Depression on Cognitive Functioning in Parkinson’s Disease”. Neuropsychology.
TEMPO Open-label Study Group. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
Hauser, RA, MF Lew, HI Hurtig, WG Ondo, J Wojcieszek, and CJ Fitzer-Attas. 2009. “TEMPO Open-Label Study Group. Long-Term Outcome of Early versus Delayed Rasagiline Treatment in Early Parkinson’s Disease.”. Mov Disord.
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology 2011;77:767-74.
Schapira, AH, P Barone, RA Hauser, Y Mizuno, O Rascol, M Busse, L Salin, N Juhel, and . 2011. “Extended-Release Pramipexole in Advanced Parkinson Disease: A Randomized Controlled Trial. Neurology 2011;77:767-74.”. Neurology.
SPECT brain imaging in patients with suspected Parkinsonian syndromes.
Hauser, RA, and DG Grosset. 2012. “SPECT Brain Imaging in Patients With Suspected Parkinsonian Syndromes.”. J Neuroimaging.